Powered by

BioSig Technologies Begins Trading on Nasdaq

Sep 22, 2018 - ICT Monitor Worldwide

(GlobeNewswire) - BioSig Technologies, Inc. (NASDAQ:BSGM) a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that shares of its common stock have begun officially trading on the Nasdaq Capital Market, under the ticker BSGM.

BioSigs listing on the Nasdaq is the Companys most recent operational achievement. In August 2018, the Company rece...